Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.

President Trump’s budget proposal for 2020 would negatively impact almost every institute at the NIH, including trimming the funding for the National Heart, Lung and Blood Institute by about $486 million.

South Dakota Gov. Kristi Noem has signed the state’s breast density reporting legislation into law. The bill goes into effect on July 1.

Once a child’s broken arm is on the mend, little to nothing is gained by having follow-up x-rays read by both radiologists and orthopedic surgeons, according to a study conducted at Case Western Reserve University and published online March 6 in the Journal of Pediatric Orthopaedics.

The American Society of Radiologic Technologists (ASRT) has elected four new officers to serve on the 2019-2020 ASRT Board of Directors.

President Trump’s proposed “Budget for a Better America” for 2020 would cut Medicare spending by approximately $845 billion and Medicaid spending by approximately $241 billion over 10 years.

The Medical Imaging & Technology Alliance (MITA) has published a new voluntary standard addressing the servicing of medical imaging equipment.

The FDA has granted accelerated approval to the combination of atezolizumab, an antibody marketed by Genentech under the name Tecentriq, and chemotherapy for certain patients with metastatic triple-negative breast cancer.